(Q28303494)
Statements
ACP-103, a 5-hydroxytryptamine 2A receptor inverse agonist, improves the antipsychotic efficacy and side-effect profile of haloperidol and risperidone in experimental models (English)
0 references
August 2007
0 references
322
0 references
2
0 references
862-70
0 references